Abstract:In calcium renal stones, calcium oxalate and calcium phosphate in various crystal forms and states of hydration can be identified. Calcium oxalate monohydrate (COM) or whewellite and calcium oxalate dihydrate (COD) or weddellite are the commonest constituents of calcium stones. Calcium oxalate stones may be pure or mixed, usually with calcium phosphate or sometimes with uric acid or ammonium urate. The aim of this study was to compare the clinical and urinary patterns of patients forming calcium stones of different composition according to infrared spectroscopic analysis in order to obtain an insight into their etiology. The stones of 84 consecutive calcium renal stone formers were examined by infrared spectroscopy. In each patient, a blood sample was drawn and analysed for serum biochemistry and a 24-h urine sample was collected and analysed for calcium, phosphate, oxalate, citrate and other electrolytes. We classified 49 patients as calcium oxalate monohydrate (COM) stone formers, 32 as calcium oxalate dihydrate (COD) stone formers and three as apatite stone formers according to the main component of their stones. Patients with COM stones were significantly older than patients with COD stones (P < 0.002). Mean daily urinary calcium and urinary saturation with respect to calcium oxalate were significantly lower in patients with COM than in those with COD stones (P < 0.000). Patients with calcium oxalate stones containing a urate component (< or = 10%) presented with higher saturation (P < 0.012) with respect to uric acid in their urine (and lower with respect to calcium oxalate and calcium phosphate, respectively P < 0.024 and P < 0.003) in comparison with patients without a urate component in the stone. Patients with calcium oxalate stones with a calcium phosphate component (> or = 15%) showed higher (P < 0.0016) urinary saturation levels with respect to calcium phosphate (and lower with respect to uric acid (P < 0.009), compared with patients forming stones without calcium phosphate or with a low calcium phosphate component. Patients with calcium stones mixed with urate had a significantly lower urinary pH (P < 0.002) and urinary calcium (P < 0.000), and patients with calcium phosphate >15%, higher urinary pH (P < 0.004) and urinary calcium (P < 0.000). In conclusion, in the evaluation of the individual stone patient, an accurate analysis of the stone showing its exact composition and the eventual presence of minor components of the stone is mandatory in order to plan the correct prophylactic treatment. Patients with "calcium stones" could require various approaches dependent on the form and hydration of the calcium crystals in their stones, and on the presence of "minor" crystalline components that could have acted as epitaxial factors.

Cyclic adenosine monophosphate: relationship to calcium metabolism and renal lithiasis

Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship

Hypertension and renal calcium transport

Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review

Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis

TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis

Renal handling of calcium in hypercalciuric calcium oxalate nephrolithiasis

Paracellular Transport and Renal Tubule Calcium Handling: Emerging Roles in Kidney Stone Disease

Renal stone disease in the 1990s: the powder keg and tinderbox theory

Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate

Understanding formation processes of calcareous nephrolithiasis in renal interstitium and tubule lumen

Calcium stone disease: a multiform reality

An overview of divalent cation and citrate handling by the kidney

Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects

Pharmacotherapy and Stone Mineral Subtype Influence Long-term Recurrence Rates in Calcium Stone Formers

Human kidney stones: a natural record of universal biomineralization

Kidney stones: an update on current pharmacological management and future directions

The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation

Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones

Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion

[Studies on the endocrinological metabolism of the parathyroid. I. The production of renal calcinosis by cyclic AMP injection in rat]